| Financial Year |
March 31 2023 |
| Monetary Funds |
154,588,599.06 |
| Held-for-trading Financial Assets |
50,314,712.33 |
| Notes Receivable |
84,834,856.85 |
| Accounts Receivable |
379,757,593.06 |
| Advances to Suppliers |
1,948,332.27 |
| Other Receivables |
20,339,226.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
162,740,428.14 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,684,028.92 |
| Total Current Assets |
867,211,776.97 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
50,783,806.43 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
21,360,784.31 |
| R&D expenses |
-- |
| Goodwill |
454,348,487.92 |
| Long-Term Deferred and Prepaid Expenses |
26,197,880.67 |
| Deferred Income Tax Assets |
10,662,195.76 |
| Other Non-Current Assets |
294,500.00 |
| Sub-Total of Non-Current Assets |
606,878,336.81 |
| Total Assets |
1,474,090,113.78 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
37,731,551.31 |
| Accounts Payable |
44,490,485.95 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,382,652.47 |
| Taxes Payable |
16,458,420.04 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
501,314.60 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,625,044.00 |
| Other Current Liabilities |
5,643,909.06 |
| Sub-Total of Current Liabilities |
124,918,455.68 |
| Long-term Loans |
-- |
| Bonds Payable |
219,789.50 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
623,130.04 |
| Deferred Income Tax Liabilities |
1,900,192.42 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
72,792,451.45 |
| Total Liabilities |
197,710,907.13 |
| Paid-In Capital(Or Share Stock) |
182,329,226.00 |
| Capital Surplus |
690,189,401.21 |
| Surplus Reserve |
13,667,883.93 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
383,378,518.73 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,276,379,206.65 |
| Owner's Equity（Stockholder's Equity） |
1,276,379,206.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,474,090,113.78 |
